JX7.F EMBECTA CORP. DL-01

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
5.72 EUR
Close of Nov 12, 2026
2.42 12.09
Market cap
EUR 324M
P/E
4.5x
P/B
-
ROE
-
Dividend yield
0.61%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is JX7.F undervalued?

Graham number

The Graham number of EMBECTA CORP. DL-01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EMBECTA CORP. DL-01 fundamental analysis

No fundamental analysis for EMBECTA CORP. DL-01 yet.

EMBECTA CORP. DL-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EMBECTA CORP. DL-01

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded …

Full company profile